89bio reports qtrly loss per share $30.63

89bio reports third quarter 2019 financial results and provides corporate update.89bio inc - bio89-100 continues to advance in phase 1b/2a nash study.89bio inc - qtrly loss per share $30.63.
ETNB Ratings Summary
ETNB Quant Ranking